Hypercontractile phenotype at rest in chronic coronary syndromes predicts impaired functional reserve and increased

Quirino Ciampi1, Yi Wang2, Lauro Cortigiani3

  • 1Division of Cardiology, Fatebenefratelli Hospital, Viale Principe di Napoli, 12, Benevento I-82100, Italy.

ESC Heart Failure
|June 6, 2026
PubMed

Insights

A hypercontractile phenotype (HP) in chronic coronary syndromes (CCS) indicates higher mortality and impaired function. Despite appearing strong, HP hearts are prognostically weaker, with reduced reserves and increased death risk.

Area of Science:

  • Cardiology
  • Echocardiography
  • Prognostic Studies

Background:

  • Transthoracic echocardiography (TTE) can identify a hypercontractile phenotype (HP) in chronic coronary syndromes (CCS).
  • HP is characterized by elevated resting left ventricular (LV) elastance, calculated as systolic blood pressure divided by end-systolic volume.
  • This phenotype presents a paradox of apparent strength with potential underlying weakness.

Purpose of the Study:

  • To determine the prognostic significance of HP in CCS patients.
  • To investigate the functional correlates of HP, including contractile and heart rate reserves.
  • To assess if HP improves mortality prediction beyond traditional measures like ejection fraction (EF).

Main Methods:

  • A prospective, multicenter study involving 10,677 CCS patients.
  • Resting TTE was used to measure LV ejection fraction (EF), stroke volume (SV), and elastance (force).
  • A subset of 5,834 patients underwent stress echocardiography to assess LV contractile reserve (LVCR) and heart rate reserve (HRR).

Main Results:

  • Patients with HP (highest force quintile) had lower resting stroke volume and higher resting EF.
  • Over a median 24-month follow-up, HP was associated with increased all-cause mortality (HR 1.531 vs. Q3).
  • HP patients demonstrated reduced LV contractile reserve (lower ΔEF) and blunted heart rate reserve during stress testing.

Conclusions:

  • HP in CCS patients identified by resting TTE signifies higher mortality risk.
  • This phenotype is linked to significant functional impairments, including reduced LV contractile and chronotropic reserves.
  • HP provides incremental prognostic value for mortality prediction when combined with EF, challenging the notion of a "stronger" heart being healthier.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...